Recruiting
Osteoarthritis
RecruitingStudy on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery
Investigational
Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery
Investigational
- Disease:Osteoarthritis
- Substances:Rivaroxaban
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Rivaroxaban
- Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

